NasdaqGS - Delayed Quote USD
Editas Medicine, Inc. (EDIT)
1.3800
-0.1200
(-8.00%)
At close: May 14 at 4:00:02 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 295.51k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LUCERA ERICK J. Chief Financial Officer | Sale at price 1.71 per share. | Direct | 7,030 | Mar 4, 2025 |
| O NEILL GILMORE NEIL Chief Executive Officer | Sale at price 1.71 per share. | Direct | 28,452 | Mar 4, 2025 |
| BURKLY LINDA Officer | Sale at price 1.71 per share. | Direct | 4,946 | Mar 4, 2025 |
| O NEILL GILMORE NEIL Chief Executive Officer | Sale at price 2.08 per share. | Direct | 3,361 | Dec 3, 2024 |
| MEI BAISONG Officer | Sale at price 2.08 per share. | Direct | 1,124 | Dec 3, 2024 |
| O NEILL GILMORE NEIL Chief Executive Officer | Sale at price 3.42 per share. | Direct | 5,325 | Sep 4, 2024 |
| MEI BAISONG Officer | Sale at price 3.42 per share. | Direct | 1,774 | Sep 4, 2024 |
| BURKLY LINDA Officer | Sale at price 5.42 per share. | Direct | 64,370 | Jul 25, 2024 |
| MEI BAISONG Officer | Sale at price 5.21 per share. | Direct | 34,456 | Jul 19, 2024 |
| O NEILL GILMORE NEIL Chief Executive Officer | Sale at price 5.50 per share. | Direct | 66,997 | Jun 4, 2024 |
| MEI BAISONG Officer | Sale at price 5.50 per share. | Direct | 2,808 | Jun 4, 2024 |
| LUCERA ERICK J. Chief Financial Officer | Sale at price 5.61 per share. | Direct | 125,404 | May 20, 2024 |
| HOPFIELD JESSICA Director | Purchase at price 5.64 per share. | Direct | 253,868 | May 13, 2024 |
| O NEILL GILMORE NEIL Chief Executive Officer | Sale at price 9.42 per share. | Direct | 732,884 | Mar 5, 2024 |
| MEI BAISONG Officer | Sale at price 9.42 per share. | Direct | 191,425 | Mar 4, 2024 |
| LUCERA ERICK J. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| O NEILL GILMORE NEIL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| MEI BAISONG Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| BURKLY LINDA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| EATON BRUCE E Chairman of the Board | Sale at price 10.90 per share. | Direct | 1,122 | Dec 5, 2023 |
| EATON BRUCE E Chief Technology Officer | Sale at price 8.21 per share. | Direct | 5,706 | Nov 14, 2023 |
| EATON BRUCE E Chief Technology Officer | Sale at price 8.40 per share. | Direct | 1,168 | Nov 7, 2023 |
| EATON BRUCE E Chief Technology Officer | Sale at price 8.82 per share. | Direct | 908 | Sep 6, 2023 |
| EATON BRUCE E Chairman of the Board | Sale at price 8.59 per share. | Direct | 6,033 | Aug 11, 2023 |
| EATON BRUCE E Chairman of the Board | Sale at price 8.39 per share. | Direct | 1,183 | Aug 8, 2023 |
| BURKLY LINDA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 24, 2023 |
| MEI BAISONG Officer | Sale at price 8.80 per share. | Direct | 37,990 | Jul 19, 2023 |
| O NEILL GILMORE NEIL Chief Executive Officer | Sale at price 9.50 per share. | Direct | 61,638 | Jun 5, 2023 |
| EATON BRUCE E Chairman of the Board | Sale at price 9.50 per share. | Direct | 998 | Jun 5, 2023 |
| LUCERA ERICK J. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 17, 2023 |
Related Tickers
NTLA Intellia Therapeutics, Inc.
7.88
-5.29%
BEAM Beam Therapeutics Inc.
17.24
-4.49%
CRSP CRISPR Therapeutics AG
35.60
-4.35%
CRBU Caribou Biosciences, Inc.
0.8189
+4.61%
SGMO Sangamo Therapeutics, Inc.
0.4380
-4.78%
VERV Verve Therapeutics, Inc.
4.3100
+3.61%
ALLO Allogene Therapeutics, Inc.
0.9528
-15.68%
BLUE bluebird bio, Inc.
4.9800
+50.45%
PRME Prime Medicine, Inc.
1.2100
-4.72%
FATE Fate Therapeutics, Inc.
0.9600
-4.00%